|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
11 December 2017 |
|
Main ID: |
ChiCTR-INR-17013574 |
|
Date of registration:
|
2017-11-28 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Clinical Study on Treating Ankylosing Spondylitis with Chinese Herbal Decoction Zhitongzhu Decoction
|
|
Scientific title:
|
Clinical Study on Treating Ankylosing Spondylitis with Chinese Herbal Decoction Zhitongzhu Decoction |
|
Date of first enrolment:
|
2018-06-01 |
|
Target sample size:
|
control group :40; Intervention group :40; |
|
Recruitment status: |
Pending |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=22959 |
|
Study type:
|
Interventional study |
|
Study design:
|
Randomized parallel controlled trial
|
|
Phase:
|
New Treatment Measure Clinical Study
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Ying Tong
|
|
Address:
|
26 Heping Road, Xiangfang District, Harbin, Heilongjiang, China
|
|
Telephone:
|
+86 186867800398 |
|
Email:
|
tymm0451@126.com |
|
Affiliation:
|
The First Affiliated Hospital of Heilongjiang Chinese Medicine Colledge |
|
|
Name:
|
Zhang Weiping
|
|
Address:
|
26 Heping Road, Xiangfang District, Harbin, Heilongjiang, China
|
|
Telephone:
|
+86 18246078873 |
|
Email:
|
1365175867@qq.com |
|
Affiliation:
|
The First Affiliated Hospital of Heilongjiang Chinese Medicine Colledge |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Forty patients diagnosed according to the International Classification of Ankylosing Spondylitis were all outpatients and inpatients with rheumatism and immunology in our hospital. Choices:
(1) male patients, aged 16 to 25 years old;
(2) did not use corticosteroids, HCQs and other drugs within 1 month before enrollment.
Exclusion criteria: (1) allergic constitution;
(2) accompanied by viral hepatitis, alcoholic liver disease, fatty liver and drug-induced liver disease.
Age minimum:
16
Age maximum:
25
Gender:
Male
|
|
Health Condition(s) or Problem(s) studied
|
|
Ankylosing spondylitis
|
|
Intervention(s)
|
|
control group :Leflunomide; Intervention group :Chinese herbalshentongzhuyudecoction;
|
|
Primary Outcome(s)
|
|
Rheumatoid factor;HL-B27;
|
|
Source(s) of Monetary Support
|
|
Self sponsored and department sponsored
|
|
Ethics review
|
Status: Not approved
Approval date: 26/08/2013
Contact:
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|